Â鶹´«Ã½Ó³»­

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 23, 2024Ìý—ÌýFY 2025 Budget Request for the Â鶹´«Ã½Ó³»­
  • Written Statement of Monica M. Bertagnolli, Director, NIH

House

Committee on Oversight and Accountability — Select Subcommittee on the Coronavirus Pandemic

• May 16, 2024Ìý—ÌýOverseeing the Overseers: A Hearing with NIH Deputy director, Dr. Lawrence Tabak
  • Written Statement of Lawrence Tabak, Principal Deputy Director, NIH

Committee on Science, Space and Technology

• February 15, 2024 — Examining Federal Science Agency Actions to Secure the U.S. Science and Technology Enterprise
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related AgenciesSS

• July 11, 2023Ìý—ÌýAccelerating Breakthroughs: How the Special Diabetes Program Is Creating Hope for those Living with Type 1 Diabetes
  • Written Statement of Griffin P. Rodgers, Director, NIDDK

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 4, 2023 — President's FY 2024 Funding Request and Budget Justification for the Â鶹´«Ã½Ó³»­
  • Written Statement of Lawrence Tabak, Performing the Duties of the Director, NIH

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 19, 2023Ìý—ÌýFY 2024 Budget Request for the Â鶹´«Ã½Ó³»­, Centers for Disease Control and Prevention, and the Administration for Strategic Preparedness and Response

Committee on Energy and Commerce, Subcommittee on Health and Oversight and Investigations

• February 8, 2023 — The Federal Response to COVID-19
  • Written Statement of Lawrence Tabak, Performing the Duties of the Director, NIH

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 26, 2021 — Â鶹´«Ã½Ó³»­â€™s FY 2022 Budget and the State of Medical Research
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• March 18, 2021 — Examining our COVID-19 Response: An Update from Federal Officials
  • Written Statement of Anthony Fauci, Director, NIAID
• April 22, 2021 — Protecting U.S. Biomedical Research: Efforts to Prevent Undue Foreign Influence
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research
• May 11, 2021 — An Update from Federal Officials on Efforts to Combat COVID-19
  • Written Statement of Anthony Fauci, Director, NIAID
• July 20, 2021 — The Path Forward: A Federal Perspective on the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID
• November 4, 2021 — Next Steps: The Road Ahead for the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID

ÌýCaucus on International Narcotics Control

• July 20, 2021 — The Federal Responses to the Drug Overdose Epidemic
  • Written Statement of Nora Volkow, Director, NIDA

House

Committee on Energy and Commerce —Subcommittee on Health

• July 29, 2021Ìý—ÌýThe Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases
  • Written Statement of Walter Koroshetz, Director, NINDS
  • Written Statement of Richard Hodes, Director, NIA

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• May 25, 2021 — FY 2022 Budget Request for the Â鶹´«Ã½Ó³»­
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

• March 17, 2021 — Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• April 28, 2021 — The Long Haul: Forging a Path Through the Lingering Effects of COVID-19
  • Written Statement of Francis Collins, Director, NIH
• July 29, 2021- The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases
  • Written Statement of Richard Hodes, Director, NIA and Walter Koroshetz, Director, NINDS
• December 2, 2021 — The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances
  • Written Statement of Nora Volkow, Director, NIDA

Select Subcommittee on the Coronavirus Crisis

• April 15, 2021 — Reaching the Light at the End of the Tunnel: A Science-Driven Approach to Swiftly Ending the Pandemic
  • Written Statement of Anthony Fauci, Director, NIAID

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2022 — FY 2023 Budget Request for the Â鶹´«Ã½Ó³»­
  • Written Statement for Lawrence Tabak, Acting Director, NIH

Committee on Health, Education, Labor, and Pensions

• January 11, 2022 — Addressing New Variants: A Federal Perspective on the COVID-19 Response
  • Written Statement of Anthony Fauci, Director, NIAID
• March 23, 2022 — Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues
  • Written Statement of Joshua Gordon, Director, NIMH
  • Written Statement of Nora Volkow, Director, NIDA
• June 16, 2022 — An Update on the Ongoing Federal Response to COVID-19: Current Status and Future Planning
  • Written Statement of Anthony Fauci, Director, NIAID
• September 14, 2022 — Stopping the Spread of Monkeypox: Examining the Federal Response
  • Written Statement of Anthony Fauci, Director, NIAID

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• May 11, 2022 — FY 2023 Budget Request for the Â鶹´«Ã½Ó³»­
  • Written Statement for Lawrence Tabak, Acting Director, NIH

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• March 14, 2019 — Review of the Ebola outbreak in the Democratic Republic of the Congo and Other Emerging Health Threats
  • Written Statement of Anthony Fauci, Director, NIAID
• April 11, 2019 — FY 2020 Â鶹´«Ã½Ó³»­ Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Aging

• April 2, 2019 — Alzheimer’s: New Directions in Biomedical Research and Caregiving
  • Written Statement of Richard Hodes, Director, NIA
• July 10, 2019 — Redefining Reality: How the Special Diabetes Program is Changing the Lives of Americans with Type 1 Diabetes
  • Written Statement of Griffin Rodgers, Director, NIDDK

Committee on Environment and Public Works

• March 28, 2019 — Examining the Federal response to the risks associated with per- and polyfluoroalkyl substances (PFAS)
  • Written Statement of Linda Birnbaum, Director, NIEHS

Committee on Finance

• June 5, 2019 — Foreign Threats to Taxpayer Funded Research: Oversight Opportunities and Policy Solutions
  • Written Statement of Lawrence Tabak, Principal Deputy Director, NIH

Committee on Homeland Security and Governmental Affairs — Permanent Subcommittee on Investigation

• November 19, 2019 — Securing the U.S. Research Enterprise from China’s Talent Recruitment Plans
  • Written Statement of Michael Lauer, Deputy Director for Extramural Research

Caucus on International Narcotics Control

• October 23, 2019 — Marijuana and America’s Health: Questions and Issues for Policy Makers
  • Written Statement of Jerome Adams, U.S. Surgeon General and Nora Volkow, Director, NIDA

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 2, 2019 — FY 2020 Â鶹´«Ã½Ó³»­ Budget Request
  • Written Statement of Francis Collins, Director, NIH
• September 25, 2019 — Investments in Medical Research at Five Institutes and Centers of the Â鶹´«Ã½Ó³»­
  • Written Statement of Francis Collins, Director, NIH
  • Written Statement of Christopher Austin, Director, NCATS
  • Written Statement of Patricia Brennan, Director, NLM
  • Written Statement of Helene Langevin, Director, NCCIH
  • Written Statement of Eliseo Perez-Stable, Director, NIMHD
  • Written Statement of Bruce Tromberg, Director, NIBIB

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• February 27, 2019 — Measles: The Continued Re-emergence of a Vaccine-Preventable Disease
  • Written Statement of Anthony Fauci, Director, NIAID
• December 4, 2019 — Flu Season: U.S. Public Health Preparedness and Response
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Science, Space, and Technology

• November 20, 2019 — Fighting Flu, Saving Lives: Vaccine Science and Innovation
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Veteran Affairs

• April 29, 2019 — Tragic Trends: Suicide Prevention Among Veterans
  • Written Statement of Shelli Avenevoli, Deputy Director, NIMH

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• July 2, 2020 — Review of Operation Warp Speed: Researching, Manufacturing, & Distributing a Safe & Effective Coronavirus Vaccine
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• March 3, 2020 — Emerging Disease Threat: How the U.S. Is Responding to COVID-19, the Novel Coronavirus
  • Written Statement of Anthony Fauci, Director, NIAID
• May 7, 2020 — Shark Tank: New Tests for COVID-19
  • Written Statement of Francis Collins, Director, NIH
• May 12, 2020 — COVID-19: Safely Getting Back to Work and Back to School
  • Written Statement of Anthony Fauci, Director, NIAID
• June 30, 2020 — COVID-19: Update on Progress Toward Safely Getting Back to Work and Back to School
  • Written Statement of Anthony Fauci, Director, NIAID
• September 9, 2020 — Vaccines: Saving Lives, Ensuring Confidence, and Protecting Public Health
  • Written Statement of Francis Collins, Director, NIH
• September 23, 2020 — COVID-19: An Update on the Federal Response
  • Written Statement of Anthony Fauci, Director, NIAID

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• March 4, 2020 — FY 2021 Â鶹´«Ã½Ó³»­ Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and Commerce

• June 23, 2020 — Oversight of the Trump Administration's Response to the COVID-19 Pandemic
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• January 15, 2020 — Cannabis Policies for the New Decade
  • Written Statement of Nora Volkow, Director, NIDA
• February 26, 2020 — The Fiscal Year 2021 HHS Budget and Oversight of the Coronavirus Outbreak

Committee on Oversight and Reform

• March 11, 2020 — Coronavirus Preparedness and Response
  • Written Statement of Anthony Fauci, Director, NIAID

Select Subcommittee on the Coronavirus Crisis

• July 31, 2020 — The Urgent Need for a National Plan to Contain the Coronavirus
  • Written Statement of Anthony Fauci, Director, NIAID

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• June 22, 2017 — FY2018 Budget Request for the Â鶹´«Ã½Ó³»­
  • Written Statement of Francis Collins, Director, NIH

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2017 — Advances in Biomedical Research
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 21, 2017 — Fentanyl: The Next Wave of the Opioid Crisis
  • Written Statement of Wilson Compton, Deputy Director, NIDA
• May 23, 2017 — U.S. Public Health Response to the Zika Virus: Continuing Challenges
  • Written Statement of Anthony Fauci, Director, NIAID

Session II

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• May 17, 2018 — FY 2019 Â鶹´«Ã½Ó³»­ Budget Request
  • Written Statement of Francis Collins, Director, NIH

Committee on Health, Education, Labor, and Pensions

• August 23, 2018 — Prioritizing Cures: Science and Stewardship at the Â鶹´«Ã½Ó³»­
  • Written Statement of Francis Collins, Director, NIH

Committee on Homeland Security and Governmental AffairsÌý—ÌýSubcommittee on Federal Oversight and Emergency Management

• September 26, 2018 — The Federal Role in the Toxic PFAS Chemical Crisis
  • Written Statement of Linda Birnbaum, Director, NIEHS

House

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 11, 2018 — FY 2019 Â鶹´«Ã½Ó³»­ Budget Request
  • Written Statement of Francis Collins, Director, NIH
• April 18, 2018 — FY19 Health and Human Services Biodefense Activities
  • Written Statement of Anthony Fauci, Director, NIAID

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• July 25, 2018 — 21st Century Cures Implementation: Updates from FDA and NIH
  • Written Statement of Francis Collins, Director, NIH

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 8, 2018Ìý—ÌýExamining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza
  • Written Statement of Anthony Fauci, Director, NIAID

Session I

Senate

Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 30, 2015 — FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH
• October 7, 2015 — The NIH: Investing in a Healthier Future
  • Written Statement for Francis Collins, Director, NIH

Committee on Health, Education Labor and Pensions

• March 10, 2015 — US Medical Innovation
  • Written Statement for Francis Collins, Director, NIH

• April 28, 2015 — Medical Innovation for Patients
  • Written Statement for Christopher Austin, Director, NCATS
  • Written Statement for Roderic Pettigrew, Director, NIBIB
• May 5, 2015 — Precision Medicine
  • Written Statement for Francis Collins, Director, NIH

• October 29, 2015 — Mental Health Issues
  • Written Statement for Thomas Insel, Director, NIMH

Committee on Special Aging

• March 25, 2015 — Alzheimer’s Disease
  • Written Statement for Richard Hodes, Director, NIA

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor Health and Human Services, Education, and Related Agencies

• March 3, 2015 — FY 2016 Budget Request for NIH
  • Written Statement for Francis Collins, Director, NIH

• April 15, 2015 — Ebola
  • Written Statement for Anthony Fauci, Director, NIAID

Committee on Energy and Commerce, Subcommittee on Health

• April 30, 2015 — 21st Century Cures Bill
  • Written Statement for Kathy Hudson, Deputy Director for Science, Outreach, and Policy

Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• February 3, 2015 — The U.S. Public Health Response to Seasonal Influenza
  • Written Statement for Anthony Fauci, Director, NIAID

• May 1, 2015 — Opioid Abuse
  • Written Statement for Nora Volkow, Director, NIDA
• November 19, 2015 — Flu Preparedness
  • Written Statement for Carole Heilman, Director, Division of Microbiology and Infectious Diseases, NIAID

Session II

Senate

Senate Committee on Appropriations — Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

• April 7, 2016 — Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

Senate Committee on Health, Education, Labor, and Pensions Committee

• February 24, 2016 — Research Conducted and Supported by the Â鶹´«Ã½Ó³»­ (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Senate Committee on Labor, Health and Human Services, Education, and Related Agencies

• February 11, 2016 — Research Conducted and Supported by the Â鶹´«Ã½Ó³»­ (NIH) in Addressing Emerging and Re-emerging Infectious Diseases Including Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House

House Committee on Energy and CommerceÌý—ÌýSubcommittee on Oversight and Investigations

• March 2, 2016 — Research Conducted and Supported by the Â鶹´«Ã½Ó³»­ (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

• April 20, 2016 — Laboratory Safety at NIH
  • Written Statement for Lawrence Tabak, Deputy Director, NIH

• June 14, 2016 — The Role of the National Institute of Allergy and Infectious Diseases Research in Combating Antibiotic Resistance
  • Written Statement for Dennis Dixon, Chief, Bacteriology and Mycology Branch, NIAID

• September 27, 2016 — Lab Safety and Inactivation of Microbiological Agents at NIH
  • Written Statement for Jeffrey Potts, Biorisk Manager, NIH

House Committee on Foreign AffairsÌý—ÌýSubcommittee on Africa, Global Health, Global Human Rights, and International Organizations and Subcommittee on the western Hemisphere

• February 10, 2016 — Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Labor, Health and Human Services, Education, and Related Agencies

• March 16, 2016 — Fiscal Year 2017 Budget Request
  • Written Statement for Francis Collins, Director, NIH

House Committee on Oversight and Government Reform

• February 24, 2016 — Research Conducted and Supported by the Â鶹´«Ã½Ó³»­ (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

House Committee on Science, Space, and Technology, Subcommittee on Research & Technology

• June 16, 2016 — SBIR/STTR Reauthorization: A Review of Technology Transfer
  • Written Statement for Michael Lauer, Deputy Director for Extramural Research

House Committee on Small Business

• March 2, 2016 — Commercializing on Innovation: Reauthorizing the Small Business Innovation Research and Small Business Technology Transfer Program
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs

House Democratic Steering and Policy Committee

• May 12, 2016 — Research Conducted and Supported by the Â鶹´«Ã½Ó³»­ (NIH) in Addressing Zika Virus Disease
  • Written Statement for Anthony Fauci, Director, NIAID

Session I

Senate

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• May 15, 2013 — Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Gary Gibbons, NHLBI Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Story Landis, NINDS Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Health, Education, Labor, and Pensions

• January 24, 2013 — Assessing the State of America’s Mental Health System
  • Written Statement for Dr. Thomas Insel, NIMH Director

House

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• March 5, 2013 — Fiscal Year 2014 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director

Session II

Senate

Committee on Appropriations

• April 29, 2014 — Federal Investments in Innovation
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Appropriations — Subcommittee on Labor, HHS, and Education

• September 16, 2014 — The Ebola Threat in West Africa
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 2, 2014 — Fiscal Year 205 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, Director, NIH
• February 27, 2014 — PHEMCE
  • Written Statement for Dr. Michael Kurilla, Associate Director for Biodefense Product Development, NIAID
• February 26, 2014 — Alzheimer’s Disease
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Special Aging

• June 25, 2014 — Brain Injuries and Diseases of Aging
  • Written Statement for Dr. Walter Koroshetz, Deputy Director, NINDS

• May 7, 2014 — Cancer Challenges
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Veteran’s Affairs

• April 30, 2014 — Veterans and Overmedication
  • Written Statement for Dr. Josephine Briggs, Director, NCCAM

Caucus on International Narcotics Control

• May 14, 2014 — America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

House

Committee on Appropriations — Subcommittee on Labor, HHS, and Education

• March 26, 2014 — Future of Biomedical Research
  • Written Statement for Dr. Francis Collins, Director, NIH

Committee on Energy and Commerce — Subcommittee on Health

• November 19, 2014 — Medical Product Development After Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Energy and Commerce — Subcommittee on Oversight and Investigation

• October 16, 2014 — Ebola Prevention and Response Efforts
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

• April 29, 2014 — Prescription Drug and Heroin Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Committee on Foreign Affairs — Subcommittee on Africa, Global Health, Global Human Rights and International Organization

• September 17, 2014 — Global Efforts to Fight Ebola
  • Written Statement for Dr. Anthony Fauci, Director, NIAID

Committee on Science, Space and Technology — Subcommittee on Research and Technology

• July 17, 2014 — Innovative Medical Achievements
  • Written Statement for Dr. Harold Varmus, Director, NCI

Committee on Small Business

• July 23, 2014 — Small Business Innovation Research and Small Business Technology Transfer Programs
  • Written Statement for Matthew Portnoy, Director, Division of Special Programs, Manager, Â鶹´«Ã½Ó³»­ SBIR/STTR Program

Committee on Oversight and Government Reform — Subcommittee on Government Operations

• June 20, 2014 — The Adverse Health Effects of Marijuana Use
  • Written Statement for Dr. Nora Volkow, Director, NIDA

• May 20, 2014 — The Federal Government’s Response to Autism
  • Written Statement for Dr. Thomas Insel, Director, NIMH

• May 14, 2014 — America’s Addiction to Opioids: Heroin and Prescription Drug Abuse
  • Written Statement for Dr. Nora Volkow, Director, NIDA

Session I

Senate

Committee on AppropriationsÌý—Ìý​Subcommittee on Labor, HHS, and Education

• May 11, 2011 — Fiscal Year 2012 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Environmental and Public Works

• February 2, 2011 — Drinking Water Contaminants
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director

Committee on Homeland Security and Government Affairs

• June 22, 2011 — Transforming Lives Through Diabetes Research
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director

House

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• July 11, 2011 — Legislative Hearing on Various Bills (including the Combating Autism Reauthorization Act)
  • Written Statement for Dr. Thomas Insel, NIMH Director

Committee on Foreign Affairs-Subcommittee on Africa, Global Health, and Human Rights

• June 23, 2011 — Global Strategies to Combat Alzheimer’s Disease
  • Written Statement for Dr. Richard Hodes, NIA Director

Committee on Science, Space, and Technology-Subcommittee on Technology and Innovation

• March 31, 2011 — The Role of Small Business in Innovation and Job Creation: The SBIR/STTR Programs
  • Written Statement for Dr. Sally Rockey, NIH Deputy Director for Extramural Research

Session II

Senate

Committee on AppropriationsÌý—ÌýSubcommittee on Labor, HHS, and Education

• March 28, 2012 — Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Anthony Fauci, NIAID Director
  • Written Statement for Dr. Richard Hodes, NIA Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)
  • Written Statement for Dr. Griffin Rodgers, NIDDK Director
  • Written Statement for Dr. Harold Varmus, NCI Director

Committee on Environmental and Public Works-Subcommittee on Water and Wildlife

• April 24, 2012 — Legislative Hearing on Various Bills (including the Great Apes Protection and Cost Savings Act of 2011)
  • Written Statement for Dr. James Anderson, NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives

Committee on Health, Education, Labor, and Pensions

• February 14, 2012 — Pain in America: Exploring Challenges to Relief
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director

Committee on Homeland Security and Government Affairs

• April 26, 2012 — Biological Security: The Risk of Dual-Use Research
  • Written Statement for Dr. Anthony Fauci, NIAID Director

House

Committee on AppropriationsÌý—Ìý​Subcommittee on Labor, HHS, and Education

• March 20, 2012 — Fiscal Year 2013 Budget Request for NIH
  • Written Statement for Dr. Francis Collins, NIH Director
  • Written Statement for Dr. Thomas Insel, NIMH Director (testified as the Acting NCATS Director)

Committee on Energy and CommerceÌý—ÌýSubcommittee on Health

• June 21, 2012 — NIH: A Review of Its Reforms, Priorities, and Progress
  • Written Statement for Dr. Francis Collins, NIH Director

Committee on Oversight and Government Reform

• December 12, 2012 — HGH Testing in the NFL: Is the Science Ready?
  • Written Statement for Dr. Lawrence Tabak, NIH Principal Deputy Director
• November 29, 2012 — 1 in 88 Children: A Look into the Federal Response to Rising Rates of Autism
  • Written Statement for Dr. Alan Guttmacher, NICHD Director

Committee on Science, Space, and Technology-Subcommittee on Investigations and Oversight and the Committee on Small Business-Subcommittee on Healthcare and Technology (joint hearing)

• April 25, 2012 — How the Report on Carcinogens Uses Science to Meet Its Statutory Obligations, and Its Impact on Small Business Jobs
  • Written Statement for Dr. Linda Birnbaum, NIEHS Director